Stella H. Park

Stella H. Park

Auto-generated profile, based on publicly available information

Stella H. Park

New York Genome Center, New York, NY, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2025 in Nature Communications
Verified
Journal Article
Open access
MSMegan D. Schertzer
Megan D. Schertzer
ASAndrew Stirn
Andrew Stirn
KIKeren Isaev
Keren Isaev
LPLaura Pereira
Laura Pereira
SPStella H. Park
Stella H. Park
DKDavid A. Knowles
David A. Knowles
Pre- and post-transcriptional mechanisms, including alternative promoters, termination signals, and splicing, play essential roles in diversifying protein output by generating distinct RNA and protein isoforms. Two major challenges in characterizing the cellular function of alternative isoforms are the lack of experimental methods to specifically and efficiently modulate isoform expression and computational tools for complex experimental design and analysis. To address these gaps, we develop and methodically test an isoform-specific knockdown strategy which pairs the RNA-targeting CRISPR/Cas13d system with guide RNAs that span exon-exon junctions. In parallel, we provide computational tools for experimental design and analysis. In this study, we demonstrate that junction-targeting achieves robust and isoform-specific RNA knockdown across diverse alternative isoform events, genes, and cell types.

5 January 2026 in Nature Biotechnology
Verified
Journal Article
Open access
JSJiayu Su
Jiayu Su
YQYiming Qu
Yiming Qu
MSMegan Schertzer
Megan Schertzer
HYHaochen Yang
Haochen Yang
JJJiahao Jiang
Jiahao Jiang
RRRaul Rabadan
Raul Rabadan
Transcript diversity including splicing and alternative 3′ end usage is crucial for cellular identity and adaptation, yet its spatial coordination remains poorly understood. Here we present SPLISOSM (spatial isoform statistical modeling), a method for detecting isoform-resolution patterns from spatial transcriptomics data. SPLISOSM uses multivariate testing with nonparametric kernels to account for spot-level and isoform-level dependencies, achieving high statistical power on sparse data. In the mouse brain, we identify over 1,000 spatially variable transcript diversity events, primarily in synaptic signaling pathways linked to neuropsychiatric disorders, and uncover both known and previously unknown regulatory relationships with region-specific RNA binding proteins. We further show that these patterns are evolutionarily conserved between mouse and human prefrontal cortex. Analysis of human glioblastoma highlights pervasive transcript diversity in antigen presentation and adhesion genes associated with specific microenvironmental conditions. Together, we present a comprehensive spatial splicing analysis in the brain under normal and neoplastic conditions.

2 July 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMegan D. Schertzer
Megan D. Schertzer
SPStella H. Park
Stella H. Park
JSJiayu Su
Jiayu Su
GSGloria M. Sheynkman
Gloria M. Sheynkman
DKDavid A. Knowles
David A. Knowles
Characterizing the extensive isoform diversity revealed by long-read RNA-sequencing remains challenging. After removal of technical artifacts, existing pipelines apply arbitrary expression thresholds that filter out bona fide transcript structures, misrepresenting diversity and hindering reproducibility. Instead of discarding isoforms, we propose a fundamentally distinct approach to quantifying isoform diversity using perplexity –the effective number of isoforms for a gene, derived from Shannon entropy–wherein every isoform, including low-abundance ones, contributes proportionally to a gene’s diversity. Analyzing 124 ENCODE4 PacBio datasets spanning 55 human cell types, we show that perplexity provides interpretable and reproducible isoform diversity measurements across genes, regulatory levels, and tissues.